Oragenics
OGEN
12 hedge funds and large institutions have $269K invested in Oragenics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
3,400% more capital inflows, than outflows
Capital inflows: $422K | Capital outflows: $12.1K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
20% more funds holding
Funds holding: 10 → 12 (+2)
1.75% more ownership
Funds ownership: 2.42% → 4.17% (+1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$165K |
| 2 |
Renaissance Technologies
New York
|
+$135K |
| 3 |
Virtu Financial
New York
|
+$74.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.8K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.29K |
| 2 |
BlackRock
New York
|
-$3.55K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$186 |
| 4 |
Morgan Stanley
New York
|
-$23 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$6 |
OGEN Hedge Fund Activity: Q1 2024 in Review
12 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2024, worth a combined $269K — down 23% from $350K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $165K. The largest seller was Fidelity Investments, cutting an estimated $8.29K.
- 12 institutional investors held Oragenics (OGEN) as of Q1 2024, up from 10 in Q4 2023.
- Funds reported $269K of Oragenics stock for Q1 2024, down 23% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q1 2024 and 1 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q1 2024 was Warberg Asset Management, an estimated $165K added.
- The largest Oragenics seller in Q1 2024 was Fidelity Investments, an estimated $8.29K sold.
Based on aggregated 13F filings for Q1 2024.